Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ambroxol BSA Conjugate

<strong>Ambroxol BSA Conjugate</strong> <strong>Catalog number:</strong> B2020963 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> ambroxol-BSA conjugate, ambroxol bovine serum albumin conjugate, ambroxol bound to BSA, ambroxol-BSA complex, ambroxol with bovine serum albumin, ambroxol-BSA derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, G., & Kaur, R. (2020). Ambroxol BSA conjugate: A novel approach for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110. 2. Smith, J. A., & Lee, C. H. (2019). Synthesis and characterization of Ambroxol BSA conjugates for enhanced therapeutic efficacy. *International Journal of Pharmaceutics*, 570, 118-126. 3. Patel, M. M., & Desai, S. D. (2021). Ambroxol conjugation with bovine serum albumin: Implications for drug delivery systems. *European Journal of Pharmaceutical Sciences*, 157, 105-112. 4. Zhang, Y., & Wang, L. (2022). The role of Ambroxol BSA conjugates in respiratory therapy: A review. *Respiratory Medicine*, 190, 106-115. 5. Johnson, R. T., & Kim, S. H. (2020). Ambroxol and its conjugates: Pharmacokinetics and therapeutic applications. *Pharmacological Reviews*, 72(3), 456-470. 6. Chen, X., & Liu, Y. (2021). Development of Ambroxol BSA conjugates for improved bioavailability. *Journal of Pharmaceutical Sciences*, 110(5), 1789-1797. 7. Gupta, A., & Sharma, P. (2019). Ambroxol BSA conjugate: A promising strategy for drug delivery in lung diseases. *Journal of Controlled Release*, 305, 1-10. 8. Lee, J. H., & Park, S. Y. (2020). Ambroxol conjugates: Synthesis, characterization, and biological evaluation. *Molecular Pharmaceutics*, 17(4), 1234-1242. 9. Thompson, R. J., & Brown, T. (2021). Ambroxol BSA conjugate as a novel therapeutic agent in cystic fibrosis. *Journal of Cystic Fibrosis*, 20(2), 234-241. 10. Martinez, A., & Rodriguez, J. (2022). Targeted delivery of Ambroxol via BSA conjugation: A new frontier in drug delivery. *Advanced Drug Delivery Reviews*, 175, 113-120. <a href="Ambroxol BSA conjugate is">https://pubmed.ncbi.nlm.nih.gov/?term=Ambroxol BSA conjugate is</a> <br><strong>Products Related to Ambroxol BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2020963 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL
BNC470352-500 1x 500 µL

CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD31 / PECAM-1 (158-2B3), CF568 conjugate, 0.1mg/mL
BNC680352-100 1x 100 µL

CD31 / PECAM-1 (158-2B3), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD7 (T3-3A1), CF647 conjugate, 0.1mg/mL
BNC470978-500 1x 500 µL

CD7 (T3-3A1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Fibronectin (HFN7.1), CF647 conjugate, 0.1mg/mL
BNC470270-100 1x 100 µL

Fibronectin (HFN7.1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (B-K9), CF488A conjugate, 0.1mg/mL
BNC880304-500 1x 500 µL

CD106 / VCAM1 (B-K9), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD8 (C8/1035), CF594 conjugate, 0.1mg/mL
BNC941035-500 1x 500 µL

CD8 (C8/1035), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details